An Overview of Abilify and Diabetes
Abilify and Diabetes Research
In clinical studies conducted before Abilify was approved, between 1 in every 100 and 1 in every 1,000 people taking Abilify developed diabetes. Since the medicine's approval, there have been several cases of extremely high blood sugar (hyperglycemia) in people taking the drug, which have led to coma or even death.
It is not entirely clear if Abilify is the cause of these cases of diabetes. People with schizophrenia (whether they are taking Abilify or not) may be at a higher risk of developing diabetes. Also, diabetes is on the rise in the general population. These factors combined make it unclear whether there is a relationship between Abilify and diabetes. However, studies suggest that people taking Abilify may be at a higher risk of developing diabetes.
Why Might Abilify Cause Diabetes?
It is not fully understood why Abilify might lead to diabetes. Weight gain is a significant risk factor for diabetes
(see Diabetes Risk Factors), and weight gain is a common side effect of Abilify
(see Abilify and Weight Gain). Abilify may also have direct effects on blood sugar, through unknown mechanisms. Abilify also might make diabetes more obvious in people with previously undiagnosed diabetes.